The global next-generation sequencing (NGS) market reached a value of US$ 13.82 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 40.25 Billion by 2027, exhibiting a CAGR of 19.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Next-generation sequencing, or high-throughput sequencing, refers to the process of determining the sequence of nucleotides in a section of the DNA. It includes procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing. It is a cost-effective solution that offers precise results with high accuracy and speed. This enables the analysis of millions of DNA molecules simultaneously, which facilitates research in the fields of personalized and genetic medicines, agriculture and animal research, and clinical diagnostics.
The increasing prevalence of chronic medical ailments, such as cancer, along with various technological advancements in the field of medical sciences, is one of the key factors driving the growth of the market. Owing to the widespread adoption of liquid biopsies in cancer diagnostics, there has been a significant increase in the utilization of NGS technologies. These technologies utilize cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection. Furthermore, the increasing adoption of genome mapping programs to predict the development of various diseases is also providing a boost to the market growth. Genetic maps are used for guiding scientists to analyze the genes that are responsible for increasing the prevalence of diabetes, heart diseases, asthma, cancer and psychiatric conditions. Additionally, various technological advancements and integration with the cloud-computing systems for improved data management, are creating a positive impact on the market growth. Other factors, including the declining costs of NGS systems and extensive research and development (R&D) activities in the field of sequencing chemistry, molecular biology and technical engineering, are projected to drive the global next-generation sequencing market further.
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.
2. What has been the impact of COVID-19 on the global next-generation sequencing (NGS) market?
3. What are the key factors driving the global next-generation sequencing (NGS) market?
4. What is the breakup of the global next-generation sequencing (NGS) market based on the sequencing type?
5. What is the breakup of the global next-generation sequencing (NGS) market based on the product type?
6. What is the breakup of the global next-generation sequencing (NGS) market based on the technology?
7. What is the breakup of the global next-generation sequencing (NGS) market based on the end-user?
8. What is the breakup of the global next-generation sequencing (NGS) market based on the application?
9. What are the key regions in the global next-generation sequencing (NGS) market?
10. Who are the key players/companies in the global next-generation sequencing (NGS) market?
Next-generation sequencing, or high-throughput sequencing, refers to the process of determining the sequence of nucleotides in a section of the DNA. It includes procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing. It is a cost-effective solution that offers precise results with high accuracy and speed. This enables the analysis of millions of DNA molecules simultaneously, which facilitates research in the fields of personalized and genetic medicines, agriculture and animal research, and clinical diagnostics.
Next-Generation Sequencing (NGS) Market Drivers:
The increasing prevalence of chronic medical ailments, such as cancer, along with various technological advancements in the field of medical sciences, is one of the key factors driving the growth of the market. Owing to the widespread adoption of liquid biopsies in cancer diagnostics, there has been a significant increase in the utilization of NGS technologies. These technologies utilize cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection. Furthermore, the increasing adoption of genome mapping programs to predict the development of various diseases is also providing a boost to the market growth. Genetic maps are used for guiding scientists to analyze the genes that are responsible for increasing the prevalence of diabetes, heart diseases, asthma, cancer and psychiatric conditions. Additionally, various technological advancements and integration with the cloud-computing systems for improved data management, are creating a positive impact on the market growth. Other factors, including the declining costs of NGS systems and extensive research and development (R&D) activities in the field of sequencing chemistry, molecular biology and technical engineering, are projected to drive the global next-generation sequencing market further.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global next-generation sequencing (NGS) market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on sequencing type, product type, technology, application and end-user.Breakup by Sequencing Type:
- Whole Genome Sequencing
- Targeted Resequencing
- Whole Exome Sequencing
- RNA Sequencing
- CHIP Sequencing
- De Novo Sequencing
- Methyl Sequencing
- Others
Breakup by Product Type:
- Instruments
- Reagents and Consumables
- Software and Services
Breakup by Technology:
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time Sequencing
- Nanopore Sequencing
- Others
Breakup by Application:
- Biomarker and Cancer
- Drug Discovery and Personalized Medicine
- Genetic Screening
- Diagnostics
- Agriculture and Animal Research
- Others
Breakup by End-User:
- Academic Institutes & Research Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.
Key Questions Answered in this Report
1. What is the expected growth rate of the global next-generation sequencing (NGS) market?2. What has been the impact of COVID-19 on the global next-generation sequencing (NGS) market?
3. What are the key factors driving the global next-generation sequencing (NGS) market?
4. What is the breakup of the global next-generation sequencing (NGS) market based on the sequencing type?
5. What is the breakup of the global next-generation sequencing (NGS) market based on the product type?
6. What is the breakup of the global next-generation sequencing (NGS) market based on the technology?
7. What is the breakup of the global next-generation sequencing (NGS) market based on the end-user?
8. What is the breakup of the global next-generation sequencing (NGS) market based on the application?
9. What are the key regions in the global next-generation sequencing (NGS) market?
10. Who are the key players/companies in the global next-generation sequencing (NGS) market?
Frequently Asked Questions about the Global Next-Generation Sequencing (NGS) Market
What is the estimated value of the Global Next-Generation Sequencing (NGS) Market?
What is the growth rate of the Global Next-Generation Sequencing (NGS) Market?
What is the forecasted size of the Global Next-Generation Sequencing (NGS) Market?
Who are the key companies in the Global Next-Generation Sequencing (NGS) Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 147 |
| Published | February 2022 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 13.82 Billion |
| Forecasted Market Value ( USD | $ 40.25 Billion |
| Compound Annual Growth Rate | 20.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
Table of Contents
1 Preface3 Executive Summary13 Value Chain Analysis15 Price Indicators
2 Scope and Methodology
4 Introduction
5 Global Next-Generation Sequencing Market
6 Market Breakup by Sequencing Type
7 Market Breakup by Product Type
8 Market Breakup by Technology
9 Market Breakup by Application
10 Market Breakup by End-User
11 Market Breakup by Region
12 SWOT Analysis
14 Porters Five Forces Analysis
16 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Agilent Technologies
- Becton Dickinson
- Company
- 10x Genomics
- BGI Group
- Eurofins Scientific
- F. Hoffmann-La Roche AG
- Illumina Inc.
- Genewiz
- Macrogen
- Oxford Nanopore Technologies
- Pacific Biosciences
- PerkinElmer
- Thermo Fisher Scientific
- Qiagen N.V.
- GenapSys Inc.
Methodology
LOADING...
